Telwave M 40mg/25mg Tablet ER

Name: Telwave M 40mg/25mg Tablet ER
Brand: Akesiss Pharma Pvt Ltd
Price: 98 INR

Prescription Required

Marketer

Akesiss Pharma Pvt Ltd

Salt Composition

Telmisartan (40mg) + Metoprolol Succinate (25mg)

Overview Telwave M 40mg/25mg Tablet ER

Cardio-Tel 40mg/25mg Extended-Release Tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use improves heart attack survival rates. Take Cardio-Tel with food daily at the same time for consistent blood levels; continue as directed by your physician. Don't discontinue, even feeling well, as hypertension is often asymptomatic; stopping may worsen your condition. A healthy diet, weight management, and regular exercise further support blood pressure control. Always follow your doctor's instructions. Potential side effects include headache, weakness, dizziness, low blood pressure, elevated potassium, occasional orthostatic hypotension (possibly with fainting), shortness of breath, nausea, vomiting, stomach pain, and tiredness. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly. Regular blood pressure, blood sugar, kidney function, urea, and electrolyte monitoring may be necessary. Inform your doctor of any kidney or liver issues before starting treatment. Pregnant or breastfeeding individuals should consult their doctor before use. Disclose all medications, especially those for hypertension or heart conditions.

Uses of Telwave M 40mg/25mg Tablet ER

Managing Elevated Blood Pressure

Major Benefits of Telwave M 40mg/25mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telwave M 40mg/25mg Extended-Release tablet whole; do not damage it by chewing, crushing, or breaking. Administer this medication with a meal.

Common Side effects of Telwave M 40mg/25mg Tablet ER:

Headache
Weakness
Dizziness
Cold extremities
Slow heart rate
Increased potassium level in blood
Decreased blood pressure
Orthostatic hypotension (sudden lowering of blood pressure on standing)
Breathlessness
Vomiting
Abdominal pain

How to use Telwave M 40mg/25mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Telwave M 40mg/25mg Extended-Release tablets with food.

How Telwave M 40mg/25mg Tablet ER works:

Each Telwave M 40mg/25mg Extended-Release tablet combines telmisartan and metoprolol succinate to reduce blood pressure.

SAFETY ADVICE

AlcoholUNSAFE

Consuming alcohol while taking Telwave M 40mg/25mg Tablet ER is unsafe.

PregnancyCONSULT YOUR DOCTOR

Extended-release Telwave M 40mg/25mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe them if the potential benefits outweigh the known dangers. Always seek medical advice.

Breast feedingSAFE IF PRESCRIBED

Extended-release Telwave M 40mg/25mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with this medication.

DrivingUNSAFE

Extended-release Telwave M 40mg/25mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects are experienced.

KidneySAFE IF PRESCRIBED

Patients with kidney disease can safely take Telwave M 40mg/25mg Extended-Release tablets without any required dosage modification.

LiverCAUTION

Patients with hepatic impairment should use Telwave M 40mg/25mg Extended-Release tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Telwave M 40mg/25mg Tablet ER :

Should you forget to take a Telwave M 40mg/25mg Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Telwave M 40mg/25mg Tablet ER

Label	Value
Addictive	None.
Medication Category	HEART

FAQs on Telwave M 40mg/25mg Tablet ER

Dizziness is a possible side effect of Telwave M 40mg/25mg Extended-Release Succinate Tablets. This side effect is more likely when standing up quickly after lying down or sitting. To minimize dizziness or fainting, stand up gradually after prolonged periods of sitting or lying.

Improving your lifestyle alongside Telwave M 40mg/25mg Tablet ER Succinate use significantly enhances your well-being. Quitting smoking is crucial, as it elevates the risk of heart attack and stroke. Weight management is important; those overweight or obese should aim for weight loss. A balanced diet rich in fruits and vegetables is recommended. Consistent physical activity strengthens the heart and lowers the risk of cardiac events.

Continue taking your prescribed Telwave M 40mg/25mg Extended-Release tablets as directed, even if you feel healthy. Abrupt cessation of Telwave M 40mg/25mg Extended-Release tablets can result in severe adverse events, including myocardial infarction and cerebrovascular accident.

Store the medication in its original, tightly sealed container or packaging, following the storage instructions provided. Discard any remaining medication. Prevent access by children, pets, and other individuals.

MRP 119

17% off

Inclusive of all taxes

Quantity:

of 10 Tablet ER

Telwave M 40mg/25mg Table...